<DOC>
	<DOC>NCT02473484</DOC>
	<brief_summary>The aim is to classify high grade glioma by matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI MSI). In order to provide more specific informations for the diagnosis and the prognosis of high grade glioma.</brief_summary>
	<brief_title>Search of Protein Biomarkers in Order to Achieve a Molecular Classification of Gliomas</brief_title>
	<detailed_description />
	<mesh_term>Glioblastoma</mesh_term>
	<mesh_term>Glioma</mesh_term>
	<criteria>Main inclusion criteria: Patients with grade III or IV glioma newly diagnosed with histological evidence Surgical indication Tumor tissue available at biobank of Lille Men and women aged â‰¥ 18 years Informed Consent signed by the patient or his legal representative. Main exclusion criteria: Antecedents of other cancers except basal cell skin cancer or carcinoma in situ of the uterus cervix Previous history of brain radiotherapy Antitumor systemic treatments (chemotherapy or targeted therapy) prior to surgery of glioma Genetic disease that may cause brain tumor, potentially radiationinduced tumor History of degenerative neurological disease prior to diagnosis contraindication to MRI</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>High Grade Glioma</keyword>
	<keyword>Proteomics</keyword>
	<keyword>MALDI-MSI</keyword>
</DOC>